 |
answer text |
<p>There are acute operational waiting time standards relating to cancer treatment,
accident and emergency (A&E) and elective care which the National Health Service
reports against on a monthly basis. These are outlined in the following table:</p><table><tbody><tr><td><p>Cancer</p></td><td><p>Target</p></td></tr><tr><td><p>Two
week wait from urgent general practitioner (GP) referral to see a specialist where
cancer is suspected</p></td><td><p>93%</p></td></tr><tr><td><p>31 day wait from diagnosis
to first definitive treatment</p></td><td><p>96%</p></td></tr><tr><td><p>62 day wait
from urgent GP referral to first definitive treatment</p></td><td><p>85%</p></td></tr><tr><td><p>Two
week wait from referral to see a specialist for investigation of breast symptoms,
even if cancer is not initially suspected</p></td><td><p>93%</p></td></tr><tr><td><p>62
day wait from a national screening service to a first treatment for cancer</p></td><td><p>90%</p></td></tr><tr><td><p>31
day wait from a decision to treat to a subsequent treatment for cancer (radiotherapy)</p></td><td><p>94%</p></td></tr><tr><td><p>31
day wait from a decision to treat to a subsequent treatment for cancer (surgery)</p></td><td><p>94%</p></td></tr><tr><td><p>31
day wait from a decision to treat to a subsequent treatment for cancer (anti-cancer
drug regimen).</p></td><td><p>98%</p></td></tr><tr><td><p>A&E</p></td><td><p>Target</p></td></tr><tr><td><p>Patients
admitted, transferred or discharged within 4 hours of arrival in A&E.</p></td><td><p>95%</p></td></tr><tr><td><p>Elective
care (referral-to-treatment)</p></td><td><p>Target</p></td></tr><tr><td><p>Patients
with incomplete pathways waiting 18 weeks or less to start consultant-led treatment.</p></td><td><p>92%</p></td></tr></tbody></table><p>
</p><p>In addition to the acute operational standards mentioned, there are also mental
health waiting times targets which are published on either a monthly or a quarterly
basis:</p><p> </p><p> </p><table><tbody><tr><td><p>Measure</p></td><td><p>Target</p></td></tr><tr><td><p>Improving
Access to Psychological Therapies (IAPT)</p></td><td><p>75% of people referred to
IAPT services should start treatment within 6 weeks of referral and 95% should start
treatment within 18 weeks of referral</p></td></tr><tr><td><p>Eating disorder services
for children and young people</p></td><td><p>By 2020/21, 95% of children with an eating
disorder will receive treatment within one week for urgent cases and within four weeks
for routine cases</p></td></tr><tr><td><p>Early intervention in psychosis</p></td><td><p>By
2020/21, at least 60% of people experiencing a first episode of psychosis commence
a National Institute for Health and Care Excellence (NICE)-recommended package of
care within two weeks of referral</p></td></tr></tbody></table><p> </p><p>The United
Kingdom’s five-year national action plan for antimicrobial resistance includes a strengthened
focus on infection prevention and control and sets an ambition to halve levels of
healthcare associated Gram-negative blood stream infections by 2023-2024. The draft
NHS Standard Contract for 2020/21 includes a proposal for annual targets for trust
and clinical commissioning group-level reductions in <em>E. coli</em>, Methicillin-Sensitive
Staphylococcus aureus, Klebsiella and Pseudomonas bloodstream infections. The draft
contract is out for consultation until 31 January 2020.</p><p> </p><p>The NHS Standard
Contract will continue to include targets for both methicillin-resistant Staphylococcus
aureus (MRSA) and Clostridium difficile (CDI). The zero-tolerance approach for MRSA
bacteraemia will continue, and all acute providers submit monthly data on all positive
MRSA bacteraemia specimens. CDI thresholds are published annually by NHS England and
NHS Improvement and all acute providers must report positive CDI specimens.</p><p>National
targets for vaccine preventable disease/immunisation are 95% national coverage for
key vaccines, and 50% coverage for the childhood flu vaccine. The UK has also committed
to meeting the World Health Organization elimination targets for hepatitis C, hepatitis
B and Tuberculosis (TB) ahead of 2030, and is committed to eradicating HIV transmission
in England by 2030 (Public Health England’s infectious disease strategy).</p>
|
|
